ADCC	antibody-dependent cell-mediated cytotoxicity
APCs	antigen-presenting cells
ATCVs	autologous tumor cell-based vaccines
BC	breast cancer
CMV	cytomegalovirus
COX-2	cyclooxygenase 2
CTL	cytotoxic T lymphocytes
CY	cyclophosphamide
DCs	dendritic cells
DOX	doxorubicin
ECD	extracellular domain
EGFR	epidermal growth factor receptor
ER	estrogen receptor
FDA	Food and Drug Administration
GM-CSF	macrophage colony-stimulating factor
HER	human epidermal growth factor receptor
HLA	human leukocyte antigen
hTERT	telomerase reverse transcriptase
ICD	intracellular domain
ICOS	inducible T-cell costimulator
iDCs	immature dendritic cells
IDO1	indoleamine 2,3-dioxygenase 1
IFN-γ	interferon gamma
IHC	immunohistochemistry
mCRPC	metastatic castrate-resistant prostate cancer
M-CSF	macrophage-colony stimulating factor
MDSCs	myeloid-derived suppressor cells
MHC	major histocompatibility complex
mRNA	messenger RNA
MUC-1	mucin-1
PR	progesterone receptor
SLPs	synthetic long peptides
TAA	tumor-associated antigens
T-DM1	trastuzumab emtansine
TGF	transforming growth factor
TNBC	triple-negative breast cancer
TSA	tumor-specific antigen
VEGF	vascular endothelial growth factor
WHO	World Health Organization